Showing 1 - 3 results of 3 for search 'Sayed K. Goda', query time: 0.02s Refine Results
  1. 1
    Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy

    Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy by Sara S. Bashraheel, Sayed K. Goda

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Production of Long-Acting CNGRC–CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment

    Production of Long-Acting CNGRC–CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment by Layla Al-mansoori, Alanod D. Al Qahtani, Philip Elsinga, Sayed K. Goda

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Correction: Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.

    Correction: Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment. by Fatma B Rashidi, Alanod D Al-Qahtani, Sara S Bashraheel, Shabnam Shaabani, Matthew R Groves, Alexander Dömling, Sayed K Goda

    Published 2023-01-01
    Get full text
    Article

Search Tools: